Title : Tigecycline-based prolonged salvage therapy in patients presenting with complex bone and joint infection.

Pub. Date : 2018 Feb

PMID : 29031650






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Tigecycline (50mg BID, mainly in combination (69.4%), mean duration of 58 days) was indicated for multidrug resistance (90.6%) and/or previous antibiotic intolerance (36.1%), and/or as second- or third-line therapy (69.4%). Tigecycline BH3 interacting domain death agonist Homo sapiens